What can we learn from parents about enhancing participation in pharmacovigilance? - Wikidata - wikimedia - TriplyDB

What can we learn from parents about enhancing participation in pharmacovigilance?

What can we learn from parents about enhancing participation in pharmacovigilance?

http://www.wikidata.org/entity/Q36729977

about

Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance.The value of patient reporting to the pharmacovigilance system: a systematic review.Patient Reporting in the EU: Analysis of EudraVigilance Data.ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.Factors affecting patient reporting of adverse drug reactions: a systematic review.Pediatric clinical pharmacology: an introduction to a series of educational papers.

P2860

Q34033938-3D6CEFF1-790F-4CF2-9CB8-93E644BDCBE0 Q34644792-0EBBE197-708C-4C73-B009-0559D98867B1 Q36112324-EF987729-DF81-4D1B-9A8A-865FC0F8FA81 Q36349268-FBE9BEB1-243A-4733-879B-7BB3B00FC391 Q38334927-A268062F-84FB-4A15-B83B-3E635FE0ECE0 Q39015017-4313E401-9388-43C9-A3CE-B12A3F254538 Q44185876-DAAC0C53-852E-44DF-B11E-56DFEE662D94

P2860

What can we learn from parents about enhancing participation in pharmacovigilance?

http://www.wikidata.org/entity/Q36729977

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

What can we learn from parents about enhancing participation in pharmacovigilance?

@ast

What can we learn from parents about enhancing participation in pharmacovigilance?

@en

type

label

What can we learn from parents about enhancing participation in pharmacovigilance?

@ast

What can we learn from parents about enhancing participation in pharmacovigilance?

@en

prefLabel

What can we learn from parents about enhancing participation in pharmacovigilance?

@ast

What can we learn from parents about enhancing participation in pharmacovigilance?

@en

P1433

Q36729977-1217C3BD-7ABA-46B1-80AE-3EC16F686FC9

P1476

Q36729977-952101B4-6E4E-4C35-9950-658AF9BFC94D

P2093

Q36729977-3221FADE-4D1D-4E47-9146-A78C9CA7F15F

Q36729977-33868164-4300-4AAD-A7CB-9D65A60C9A10

Q36729977-ACFE9AB6-E569-4F1F-BC47-B9D90C073C36

Q36729977-FF81F0DC-B636-451A-A3B9-735F35EB2A3C

P2860

Q36729977-048615DC-4471-45DA-8D40-5894ED045DBF

Q36729977-0ACA97BE-2A21-4129-A308-21FACDEF3E22

Q36729977-1EB769C5-FF75-40FE-9905-5352638120AD

Q36729977-39AAF30B-B19A-4AD3-A0B9-49AFEEFD81CD

Q36729977-3D52E1B5-50C7-4655-9F9C-3A668DB1E552

Q36729977-3E7CF2AF-468C-4CAF-A3AF-B4B9AC9F669E

Q36729977-3F77163B-0F55-4D2A-8A6D-65D99581A9C2

Q36729977-4CCD06A9-780D-4E71-99B8-50214605DB3F

Q36729977-5C4839F5-37D7-49CC-91ED-1105AF190BFC

Q36729977-75FCA8C0-9CD5-4729-A986-AE5E21275B35

P304

Q36729977-276A1DAC-E7DC-4DA6-98E3-CD64F46C007B

P31

Q36729977-A551C695-419D-4544-9994-015BEECF846C

P356

Q36729977-351F518D-B3A3-4901-BC17-DC57F5F3D009

P407

Q36729977-AD3BFB96-DFFB-4817-8D3D-42A439ED92B4

P433

Q36729977-98BFB9C7-C181-49AC-A098-C3092A82C83B

P478

Q36729977-73F2942F-F4D6-40B8-8102-E6BDD7BAD9C6

P50

Q36729977-1B585B33-3D67-40F9-845A-50A3A1E8CBA3

Q36729977-33722E8C-C055-47B7-AF23-735E2B9792B2

Q36729977-CF08A936-DBF9-4C00-9656-3F036051BE3B

Q36729977-E14EAB9F-FF08-4D2F-9FAF-A7F068DDF19C

P577

Q36729977-1EED093A-8A2F-4CCA-A275-40680E6FA230

P5875

Q36729977-95DC8DAE-3C94-4202-8B5B-A2690406030F

P698

Q36729977-EFB4345A-6EA4-44C8-BEE4-E50B0A2B08C2

P932

Q36729977-3CBD31BF-9E27-4A0A-8047-2971D19E2EFA

P356

J.1365-2125.2012.04441.X

P1433

British Journal of Clinical Pharmacology

P1476

What can we learn from parents about enhancing participation in pharmacovigilance?

@en

P2093

Anthony J Nunn

http://www.w3.org/2001/XMLSchema#string

Hannah Hesselgreaves

http://www.w3.org/2001/XMLSchema#string

Janine Arnott

http://www.w3.org/2001/XMLSchema#string

Rosalind L Smyth

http://www.w3.org/2001/XMLSchema#string

P2860

Unlicensed and off label prescription of drugs to children: population based cohort study.

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands.

The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective.

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital

Patients' role in reporting adverse drug reactions.

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination.

Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination.

Under-reporting of adverse drug reactions : a systematic review.

What worries parents when their preschool children are acutely ill, and why: a qualitative study.

P304

1109-1117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2012.04441.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Munir Pirmohamed

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230706058

http://www.w3.org/2001/XMLSchema#string

P698

22905902

http://www.w3.org/2001/XMLSchema#string

P932

3612729

http://www.w3.org/2001/XMLSchema#string